Banu Rudran
Publications by Year
Research Areas
Pneumonia and Respiratory Infections, COVID-19 Clinical Research Studies, Cell Adhesion Molecules Research, Chronic Obstructive Pulmonary Disease (COPD) Research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial(2021)323 cited
- → P214 Acute exacerbations of COPD: a review of resuscitation status and associations with prognostic factors in hospital admissions(2011)2 cited
- → P1.03-19 Antibody Blockade of Integrin Alpha-V-Beta-6 (avb6) as a Novel Treatment for NSCLC(2018)
- → Use of COPD assessment (CAT) test in monitoring acute exacerbations(2011)
- → 6: Development of non-invasive imaging of integrin alpha-v-beta-6 (αvβ6)-positive lung cancers in advance of testing αvβ6-targeted therapies(2017)
- → Blockade of integrin alpha-v-beta-6 (αvβ6) reduces the invasive potential of NSCLC(2018)
- → Use Of COPD Assessment Test (CAT) To Monitor Recovery From An Acute Exacerbation(2011)
- → 7: The integrin αvβ6: a new target for therapy in non-small cell lung cancer(2015)
- Development of non-invasive imaging of integrin alpha-v-beta-6 (alpha v beta 6)-positive lung cancers in advance of testing alpha v beta 6-targeted therapies(2017)